Approval · Notice of Compliance 1402 · 2003
GAMUNEX: Notice of Compliance 1402
Issued August 11, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1402
- Date
- August 11, 2003
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GAMUNEX | 02247724 | Marketed |
Medicinal ingredients
- IMMUNOGLOBULIN (HUMAN) 10 G per 100ML